polycystic ovary syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Female patients who meet the diagnostic criteria for PCOS in the Diagnostic Criteria and Treatment Specifications for Polycystic Ovary Syndrome formulated by Chinese experts in 2011; 2. Aged 18-40 (Inclusion boundary value); 3. BMI: 20-40 kg/m2 (Inclusion boundary value); 4. Patients who are willing to accept the diet intervention program; 5. Patients who volunteered to participate in this study and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with thyroid disease, adrenal disease, hyperprolactinemia, pituitary tumor and/or other diseases causing hyperandrogenic and non-ovulation. Or combined with cardiovascular disease, liver and kidney insufficiency, malignant tumor, type 1 or type 2 diabetes and/or other chronic diseases; 2. Patients with medical histories of long-acting hormone drugs and drugs affecting metabolism 3 months before treatment; 3. Patients receiving ovulation-promoting drugs; 4. Lactating women; 5. Vulnerable groups, including mental illness, cognitive impairment, critically ill patients, juveniles, pregnant women, illiterates, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery of menstrual patterns; | — |
Secondary
| Measure | Time frame |
|---|---|
| luteinizing hormone (LH);follicle-stimulating hormone (FSH);Estradiol (E2);Testosterone (T);Prolactin (PRL);progesterone (PROG);Fasting insulin (FINS);Fasting Plasma Glucose;Total cholesterol (TC);Triglyceride (TG);high density lipoprotein (HDL);low density lipoprotein (LDL);Insulin resistance index (HOMA-IR); | — |
Countries
China
Contacts
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University